# EASE (Efficacy of ATX01 Study in Erythromelalgia)

> **NCT05917912** · PHASE2 · COMPLETED · sponsor: **AlgoTherapeutix** · enrollment: 14 (actual)

## Conditions studied

- Erythromelalgia

## Interventions

- **DRUG:** Amitriptyline Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05917912
- **Lead sponsor:** AlgoTherapeutix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-14
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-02-29
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05917912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05917912, "EASE (Efficacy of ATX01 Study in Erythromelalgia)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05917912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*